Statins harms exaggerated, benefits underestimated, major Lancet Journal review shows

Misleading reports warning patients off taking their statins have exaggerated their harms and underestimated their benefits, say the researchers of a major review. Claims that the cholesterol-busting drugs cause high rates of serious side effects had dealt a “serious cost to public health”, and had convinced some patients to stop taking their medication, the scientists of the sweeping Lancet-published review said. The real risk of obesity revealed New findings from the Sax Institute’s 45 And Up Study show obesity causes a markedly higher risk of type 2 diabetes. Video courtesy SBS World News, 6.30pm nightly. In a move the review’s authors…
View More/Source Article